NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) will likely be releasing its earnings data before the market opens on Tuesday, March 25th. Analysts expect NovaBay Pharmaceuticals to post earnings of ($0.19) per share and revenue of $2.50 million for the quarter.

NovaBay Pharmaceuticals Stock Performance

NovaBay Pharmaceuticals stock opened at $0.64 on Tuesday. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $9.08. The stock has a market capitalization of $2.71 million, a PE ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.